THERAtRAME
ActiveSummary
The annual accounts of THERAtRAME for financial year 2025 show a net loss of 79% of total assets and of 273% of the equity at the start of that year. The 2025 annual accounts show equity of €1.8m and a net result of -€2.1m. Equity is shrinking by about 2.7% per year across the filed financial years. Its solvency ranks better than 60% of 240 sector peers (NACE 72, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).
Articles of association
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “• NOSHAQ PARTNERS SRL, administrateur, représentée par son représentant permanent Mme LIMBOURG Marleen; • M. ALLAER Didier, administrateur…”deed of 23-04-2024
- Board ruleHow the board is made up, meets and takes decisions.
- “Conseil d’administration, 11” (deed in French)deed of 29-05-2026
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Obligation de suite, 9.6 §1 (ii)” (deed in French)